Reduced mortality, complications, and economic burden among medicare beneficiaries receiving influenza antivirals

References

• Centers for Disease Control and Prevention. Estimated Influenza Illnesses, Medical visits, Hospitalizations, and Deaths in the United States—2018–2019 influenza season [Internet]. Influenza Flu. 2020 [cited 2020 Oct 20]. Available from: https://www.cdc.gov/flu/about/burden/2018-2019.html.
   Google Scholar
• Putri WCWS, Muscatello DJ, Stockwell MS, et al. Economic burden of seasonal influenza in the United States. Vaccine. 2018;36(27):3960–3966. doi: 10.1016/j.vaccine.2018.05.057.
   PubMed Web of Science ®Google Scholar
• Ozawa S, Portnoy A, Getaneh H, et al. Modeling the economic burden of adult vaccine-preventable diseases in the United States. Health Aff. 2016;35(11):2124–2132. doi: 10.1377/hlthaff.2016.0462.
   PubMed Web of Science ®Google Scholar
• Uyeki TM. Preventing and controlling influenza with available interventions. N Engl J Med. 2014;370(9):789–791. doi: 10.1056/NEJMp1400034.
   PubMed Web of Science ®Google Scholar
• Matias G, Taylor R, Haguinet F, et al. Estimates of hospitalization attributable to influenza and RSV in the US during 1997–2009, by age and risk status. BMC Public Health. 2017;17(1):271. doi: 10.1186/s12889-017-4177-z.
   PubMedGoogle Scholar
• Czaja CA, Miller L, Alden N, et al. Age-related differences in hospitalization rates, clinical presentation, and outcomes among older adults hospitalized with influenza—U.S. Influenza hospitalization surveillance network (FluSurv-NET). Open Forum Infect Dis. 2019;6:ofz225.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services, Administration for Community Living. Profile of Older Americans [Internet]. Adm. Community Living. 2021. Available from: https://acl.gov/aging-and-disability-in-america/data-and-research/profile-older-americans.
   Google Scholar
• Grohskopf LA, Blanton LH, Ferdinands JM, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices—United States, 2022–23 influenza season. MMWR Recomm Rep. 2022;71(1):1–28. doi: 10.15585/mmwr.rr7101a1.
   PubMedGoogle Scholar
• Treanor JJ. Influenza vaccination. Solomon CG, editor. N Engl J Med. 2016;375(13):1261–1268. doi: 10.1056/NEJMcp1512870.
   PubMed Web of Science ®Google Scholar
• Paules CI, Fauci AS. Influenza vaccines: good, but We can do better. J Infect Dis. 2019;219(Suppl_1):S1–S4. doi: 10.1093/infdis/jiy633.
   PubMedGoogle Scholar
• Nichol KL, Nordin JD, Nelson DB, et al. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med. 2007;357(14):1373–1381. doi: 10.1056/NEJMoa070844.
   PubMed Web of Science ®Google Scholar
• Beyer WEP, McElhaney J, Smith DJ, et al. Cochrane re-arranged: support for policies to vaccinate elderly people against influenza. Vaccine. 2013;31(50):6030–6033. doi: 10.1016/j.vaccine.2013.09.063.
   PubMed Web of Science ®Google Scholar
• Demicheli V, Jefferson T, Ferroni E, et al. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. [Internet]. 20182(2):CD001269. doi: 10.1002/14651858.CD001269.pub6.
   Web of Science ®Google Scholar
• Centers for Disease Control and Preventionl. Influenza Vaccination Coverage by Season. [Internet]. 2021 [cited 2022 Sep 9]. Available from: https://www.cdc.gov/flu/fluvaxview/coverage-by-season.htm.
   Google Scholar
• Zachary KC. Seasonal influenza in adults: Treatment [Internet]. UpToDate;2021 [cited 2021 Dec 8]. Available from: https://www.uptodate.com/contents/seasonal-influenza-in-adults-treatment.
   Google Scholar
• Centers for Disease Control and Prevention. Influenza antiviral medications: summary for clinicians [Internet]. Influenza Flu. 2021 [cited 2021 Dec 8]. Available from: https://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm.
   Google Scholar
• Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical practice guidelines by the infectious diseases society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa. Clin Infect Dis. 2019;68(6):895–902. doi: 10.1093/cid/ciy874.
   PubMed Web of Science ®Google Scholar
• TAMIFLU® (oseltamivir phosphate) - PRESCRIBING INFORMATION. [Internet]. Roche; 2012 [cited 2022 Sep 7]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021087s06_2lbl.pdf.
   Google Scholar
• RAPIVABTM (peramivir injection) - PRESCRIBING INFORMATION. [Internet]. BioCryst Pharmaceuticals, Inc; 2014 [cited 2022 Sep 7]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206426lbl.pdf.
   Google Scholar
• RELENZA (zanamivir inhalation powder) - PRESCRIBING INFORMATION. [Internet]. GlaxoSmithKline. 2018 [cited 2022 Sep 7]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021036s030lbl.pdf.
   Google Scholar
• XOFLUZA (baloxavir marboxil) - PRESCRIBING INFORMATION. [Internet]. Genentech USA, Inc.; 2018 [cited 2022 Sep 7]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210854s000lbl.pdf.
   Google Scholar
• Dobson J, Whitley RJ, Pocock S, et al. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet. 2015;385(9979):1729–1737. doi: 10.1016/S0140-6736(14)62449-1.
   PubMed Web of Science ®Google Scholar
• Venkatesan S, Myles PR, Leonardi-Bee J, et al. Impact of outpatient neuraminidase inhibitor treatment in patients infected with influenza A(H1N1)pdm09 at high risk of hospitalization: an individual participant data metaanalysis. Clin Infect Dis. 2017;64(10):1328–1334. doi: 10.1093/cid/cix127.
   PubMed Web of Science ®Google Scholar
• Hayden FG, Sugaya N, Hirotsu N, et al. Baloxavir marboxil for uncomplicated influenza in adults and adolescents. N Engl J Med. 2018;379(10):913–923. doi: 10.1056/NEJMoa1716197.
   PubMed Web of Science ®Google Scholar
• Heneghan CJ, Onakpoya I, Jones MA, et al. Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data. Health Technol Assess. 2016;20(42):1–242. doi: 10.3310/hta20420.
   PubMed Web of Science ®Google Scholar
• Doll MK, Winters N, Boikos C, et al. Safety and effectiveness of neuraminidase inhibitors for influenza treatment, prophylaxis, and outbreak control: a systematic review of systematic reviews and/or meta-analyses. J Antimicrob Chemother. 2017;72(11):2990–3007. doi: 10.1093/jac/dkx271.
   PubMed Web of Science ®Google Scholar
• Stewart RJ, Flannery B, Chung JR, et al. Influenza antiviral prescribing for outpatients with an acute respiratory illness and at high risk for influenza-associated complications during 5 influenza seasons—United States, 2011–2016. Clin Infect Dis. 2018;66(7):1035–1041. doi: 10.1093/cid/cix922.
   PubMed Web of Science ®Google Scholar
• Spagnuolo PJ, Zhang M, Xu Y, et al. Effects of antiviral treatment on influenza-related complications over four influenza seasons: 2006–2010. Curr Med Res Opin. 2016;32(8):1399–1407. doi: 10.1080/03007995.2016.1176016.
   PubMed Web of Science ®Google Scholar
• Wallick C, Wu N, To TM, et al. Antiviral use is associated with a decrease in the rate of influenza-related complications, health care resource utilization, and costs. J Med Econ. 2021;24(1):386–393. doi: 10.1080/13696998.2021.1889572.
   PubMed Web of Science ®Google Scholar
• Neuberger EE, To TM, Seetasith A, et al. Antiviral use and health care use among patients with rheumatoid arthritis and influenza in three influenza seasons, 2016‐2019. ACR Open Rheumatol. 2022;4(7):631–639. doi: 10.1002/acr2.11441.
   PubMedGoogle Scholar
• Bolge SC, Kariburyo F, Yuce H, et al. Predictors and outcomes of hospitalization for influenza: real-World evidence from the United States medicare population. Infect Dis Ther. 2021;10(1):213–228. doi: 10.1007/s40121-020-00354-x.
   PubMed Web of Science ®Google Scholar
• Austin PC. A comparison of 12 algorithms for matching on the propensity score. Stat Med. 2014;33(6):1057–1069. doi: 10.1002/sim.6004.
   PubMed Web of Science ®Google Scholar
• Rosenbaum PR, Rubin DB. The Central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41–55. doi: 10.1093/biomet/70.1.41.
   Web of Science ®Google Scholar
• Littnerová S, Jarkovský J, Pařenica J, et al. Why to use propensity score in observational studies? Case study based on data from the czech clinical database AHEAD 2006-09. Cor Vasa. 2013;55(4):e383–e390. doi: 10.1016/j.crvasa.2013.04.001.
   Google Scholar
• Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399–424. doi: 10.1080/00273171.2011.568786.
   PubMed Web of Science ®Google Scholar
• Chow EJ, Rolfes MA, O'Halloran A, et al. Respiratory and nonrespiratory diagnoses associated with influenza in hospitalized adults. JAMA Netw Open. 2020;3(3):e201323. doi: 10.1001/jamanetworkopen.2020.1323.
   PubMed Web of Science ®Google Scholar
• Agency for Healthcare Research and Quality. HCUP Chronic Condition Indicator [Internet]. Healthc. Cost Util. Proj. HCUP. 2015 [cited 2022 May 10]. Available from: www.hcup-us.ahrq.gov/toolssoftware/chronic/chronic.jsp.
   Google Scholar
• Herrera AP, Snipes SA, King DW, et al. Disparate inclusion of older adults in clinical trials: priorities and opportunities for policy and practice change. Am J Public Health. 2010;100 1(Suppl 1):S105–S112. doi: 10.2105/AJPH.2009.162982.
   Google Scholar
• IBM Watson HealthTM. IBM MarketScan Research Databases for Health Services Researchers [Internet]. Somers, NY: IBM Corporation; 2019 [cited 2019 Oct 15]. Available from: https://www.ibm.com/downloads/cas/6KNYVVQ2.
   Google Scholar
• Feemster KA, Leckerman KH, Middleton M, et al. Use of administrative data for the identification of laboratory-confirmed influenza infection: the validity of influenza-Specific ICD-9 codes. J Pediatric Infect Dis Soc. 2013;2(1):63–66. doi: 10.1093/jpids/pis052.
   PubMedGoogle Scholar
• Centers for Disase Control and Prevention. Preliminary Estimated Influenza-Related Illnesses, Medical Visits, Hospitalizations, and Deaths in the United States – 2021-2022 Influenza Season [Internet]. Influenza Flu. 2023 [cited 2024 Jan 24]. Available from: https://www.cdc.gov/flu/about/burden/2021-2022.htm.
   Google Scholar
• Baser O, Samayoa G, Yapar N, et al. Use of open claims vs closed claims in health outcomes research. JHEOR. 2023;10:44–52. doi: 10.36469/jheor.2023.87538.
   Google Scholar
• Liu F, Panagiotakos D. Real-world data: a brief review of the methods, applications, challenges and opportunities. BMC Med Res Methodol. 2022;22(1):287. doi: 10.1186/s12874-022-01768-6.
   PubMed Web of Science ®Google Scholar